Glaucoma refers to chronic degenerative disease and is deemed as the second leading cause of blindness (WHO). It is further estimated that over 60 Mn suspected glaucoma cases are prevalent worldwide. Medication has remained a mainstay of glaucoma treatment for a long time. However, due to lack of overt symptoms, use of multiple drug regimen, and possible inefficiency of drugs, there has been a reported 50% compliance to drug treatment. Such dismal compliance has resulted in companies introducing stent-like devices for treating glaucoma. Minimally invasive glaucoma surgery (MIGS) is also being increasingly adopted for glaucoma treatment.
The purpose of this research study titled ‘Glaucoma Surgical Devices Market - Growth, Future Prospects, and Competitive Analysis, 2023 – 2030’ is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global glaucoma surgical devices market. This report presents and analyzes the major trends prevalent in the global glaucoma surgical devices market and the market size and forecast.
This report categorizes the global glaucoma surgical devices market in terms of device type, usage areas, and geographical distribution. Based on device type, the global glaucoma surgical devices market is categorized into glaucoma drainage devices, implants and stents, glaucoma laser devices, glaucoma surgical systems, and other surgical accessories (disposables and instruments). Ambulatory surgical centers and hospitals are the key usage areas of these devices considered for the purpose of this study.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global glaucoma surgical devices market. Competition assessment tools such as, major agreements, partnerships and collaborations, market attractiveness assessment, and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the glaucoma surgical devices market. The key players profiled in this report are Alcon, Inc., Abbott Laboratories, Inc., Carl Zeiss Meditec AG, Endo Optiks, Inc., Ellex Medical Lasers Limited, Glaukos, InnFocus, Inc., Iridex Corporation, Lumenis Ltd., and Nidek Co., Ltd.
Hospitals currently dominate the global glaucoma surgical devices market in terms of revenue generation.
Among the above device types, glaucoma drainage devices segment holds the largest revenue share in the global glaucoma surgical devices market. These devices assist in diverting aqueous humor from anterior chamber to external reservoir. Drainage devices have demonstrated success in treating complicated cases such as neovascular glaucoma, pediatric glaucoma and uveitic glaucoma. The Molteno implant is the most prominent type of drainage device with the latest versions offering better treatment outcomes, enhanced IOP control and reduced acute postoperative hypotony. At present, there is a wide range of glaucoma drainage devices available in the market in terms of design, material, size and presence or absence of IOP valve. Glaucoma drainage devices effectively provide IOP control that has failed before surgery or in patients with poor prognosis. Most studies have also demonstrated overall success rates of 50% to 80% at 2 years follow-up, subject to the type of glaucoma and the implant.
Geographically, the global glaucoma surgical devices market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
North America and Western Europe together occupy the largest revenue share in the global glaucoma surgical devices market. These regions house some of the major market incumbents and are characterized by presence of evolved healthcare infrastructure, favorable regulatory system, and better reimbursement policies. North America and Europe also deliver some of the most sophisticated and advanced devices in the global market. However, with rapid improvement in healthcare infrastructure, increasing awareness, and rising pool of patients with eye disorders. Moreover, realizing the prominence of these factors, dominant market players are increasingly moving their strategies towards penetrating in the emerging markets of Asia Pacific.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Glaucoma Surgical Devices market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Device
| |
Usage Area
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report